Page last updated: 2024-10-26

dipyridamole and Pancytopenia

dipyridamole has been researched along with Pancytopenia in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Pancytopenia: Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hofer, M1
Pospísil, M1
Znojil, V1
Vacek, A1
Weiterova, L1
Holá, J1
Vácha, J1

Other Studies

1 other study available for dipyridamole and Pancytopenia

ArticleYear
Drugs elevating extracellular adenosine promote regeneration of haematopoietic progenitor cells in severely myelosuppressed mice: their comparison and joint effects with the granulocyte colony-stimulating factor.
    European journal of haematology, 2002, Volume: 68, Issue:1

    Topics: Adenosine; Adenosine Monophosphate; Animals; Blood Cell Count; Bone Marrow; Carboplatin; Dipyridamol

2002